A novel EGR‐1 dependent mechanism for YB‐1 modulation of paclitaxel response in a triple negative breast cancer cell line

Overview of attention for article published in International Journal of Cancer, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Readers on

mendeley: 40 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER

Application WO-2021214119-A1

World Intellectual Property Organisation (WIPO)

28 Oct 2021

Therapeutic combination for the treatment of breast cancer

N/A IT-202000008710-A1

Italy

23 Oct 2021

A kind of gene ZSWa significantly increasing cell ABCC1 gene expression

Application CN-109777803-A

China

21 May 2019

Biomarkers for Predicting Triple Negative Breast Cancer Prognostication

Grant KR-101966493-B1

Republic of Korea

05 Apr 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.